• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Braxia Scientific Corp (OP: BRAXF )

    0.0033 +0.0006 (+22.22%)
    Streaming Delayed Price Updated: 11:27 AM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 19,650
    Open 0.0033
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.0027
    Today's Range 0.0027 - 0.0033
    52wk Range 0.0013 - 0.0098
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    I Saw Trillions Of Atoms In My Hand Vibrating At A Certain Frequency, Says Zappy Zapolin Describing His First Psychedelics Experience
    Via Benzinga
    Psychedelics Headlines: Predicting Readiness, Correcting The Hype, Good And Bad Drugs, Training Programs And More
    Via Benzinga

    Performance

    YTD
    -29.79%
    -29.79%
    1 Month
    +73.68%
    +73.68%
    3 Month
    +65.00%
    +65.00%
    6 Month
    -40.00%
    -40.00%
    1 Year
    -55.41%
    -55.41%

    More News

    Read More
    Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream'
    Via Benzinga
    Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
    Via Benzinga
    Braxia Scientific's Q2 2024: Cash Burn Over But Income Low, What's Next For Psychedelics Company?
    Via Benzinga
    Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
    Via Benzinga
    Braxia Scientific Faces Challenges In Accessing Public Market Capital, Reports Q1 Loss
    Via Benzinga
    Psyched: Dubai Psychedelics Event, Key Receptor Discovered, Drew Barrymore, Oprah's Guest, Swiss MDMA & More
    Via Benzinga
    BetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments Continue
    Via Benzinga
    Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
    Via Benzinga
    Major Ketamine Clinics Chain Decides Not To Pursue Acquisition Deal
    Via Benzinga
    Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
    Via Benzinga
    Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals
    Via Benzinga
    Irwin Naturals Acquires Ketamine Clinic In Kentucky Adding $3M In Projected EBITDA
    Via Benzinga
    Irwin Naturals Signs LOI To Acquire Braxia Scientific Expanding Its Network Of Mental Health Clinics
    Via Benzinga
    6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements
    Via Benzinga
    Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
    Via Benzinga
    Braxia Scientific Q2 2023 Financial Results: Health Clinic Ketamine Treatments Increases 34.5% YoY
    Via Benzinga
    Psyched: CA's Psychedelic-Assisted Treatments, Ketamine Therapy, Near-Death Experience And More
    Via Benzinga
    Ketamine Therapy At Your Doorstep, Growing Number Of Clinics Offer This Treatment Option
    Via Benzinga
    Great Psychedelics And Business Events Are Coming In Q4: Check Them Out Here
    Via Benzinga
    4 Psychedelics Companies Post Financial Results: Learn How Field Trip, Wesana, Braxia and Irwin Naturals Performed
    Via Benzinga
    Telehealth Market News: Braxia Scientific Enters Industry By Acquiring Ketamine Treatment Platform In Florida
    Via Benzinga
    Braxia Scientific Fiscal 2022 Revenue Grows 47.5% YoY, What About Net Loss?
    Via Benzinga
    Canadian Special Access Program Further Authorizes Novel Psychedelic Drugs For Emergency Treatments
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.